Drug lookup
Drug reference

Flucytosine

Antifungal

Also known as Ancotil

AntifungalATC null
CDSCO approved
EXCRETION
not curated
INTERACTIONS
3 major
SEVERE in our sources
PREGNANCY
Teratogenic in animal studies; manufacturer advises use only if potential benefit outweighs risk.
FDA category + note
Top interactionssee all 6
  • CladribineSevereDatabaseDDInter
  • ClozapineSevereDatabaseDDInter
  • DeferiproneSevereDatabaseDDInter

Mechanism

No specific mechanism of action described in the provided text.

Indications

Systemic yeast and fungal infectionsAdjunct to amphotericin in severe systemic candidiasis and in other severe or long-standing infectionsCryptococcal meningitis (adjunct to amphotericin)Cryptococcal meningitis (in combination with amphotericin B)Cryptococcus neoformansTorulaChromoblastomycesFew strains of CandidaCryptococcosis (meningeal and nonmeningeal) in synergistic action with amphotericin BInduction therapy for cryptococcal meningitis (in combination with Amphotericin B)Treatment of candidal meningitis (in combination with Amphotericin B)Treatment of candidal endocarditis (in combination with Amphotericin B)

Dosing

Adult
Systemic yeast and fungal infections: Usual dose 200 mg/kg daily in 4 divided doses usually for not more than 7 days, alternatively 100 150 mg/kg daily in 4 divided doses, lower dose may be sufficient for extremely sensitive organisms (BY INTRAVENOUS INFUSION). Cryptococcal meningitis (adjunct to amphotericin): 100 mg/kg daily in 4 divided doses for 2 weeks (BY INTRAVENOUS INFUSION).
Renal adjustment
Use 50 mg/kg every 12 hours if creatinine clearance 20 40 mL/minute; use 50 mg/kg every 24 hours if creatinine clearance 10 20 mL/minute; use initial dose of 50 mg/kg if creatinine clearance less than 10 mL/minute and then adjust dose according to plasma-flucytosine concentration.

Contraindications

  • Sole therapy (except occasionally in chromoblastomycosis) due to rapid development of resistance
  • Other fungi and bacteria (insensitive)

Side effects

Common
diarrhoeaheadachenausearashsedationvertigovomitingDose-dependent bone marrow depressionGastrointestinal disturbances (particularly enteritis and diarrhoea)Mild and reversible liver dysfunctionBone marrow suppressionLiver toxicity
Serious
  • Agranulocytosis
  • aplastic anaemia
  • blood disorder
  • cardiotoxicity
  • confusion
  • hallucination
  • hepatic disorders
  • leucopenia
  • seizure
  • thrombocytopenia
  • toxic epidermal necrolysis
  • ventricular dysfunction
  • Bone marrow depression

Pregnancy & lactation

Pregnancy

Teratogenic in animal studies; manufacturer advises use only if potential benefit outweighs risk.

Lactation

Manufacturer advises avoid.

Drug interactions

Cladribine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Clozapine
Severe
Database

Drug interaction classified as: synergy

Source: DDInter

Deferiprone
Severe
Database

Clinical effect not specified

Source: DDInter

Fluconazole
Moderate
Textbook

As effective for cryptococcal meningitis induction therapy as 1 week of amphotericin B plus flucytosine. This is an all-oral regimen.

Consider this combination for cryptococcal meningitis induction therapy, especially in resource-limited regions where it is easier to administer.

Source: G&G 14e · p1197

Amphotericin B
Moderate
Database

Improved survival in cryptococcal meningitis compared to amphotericin B alone (gold standard for treatment).

This combination is the gold standard for treatment of cryptococcal meningitis.

Source: DDInter

Cytarabine
Moderate
Database

Cytarabine antagonises antifungal activity

Avoid concurrent use

Source: Kimi deep-research + Cla

6 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.

Related guidelines

Other Antifungal drugs

Ask House about Flucytosine

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, Katzung·Verified: 2026-05-10 · House clinical team